Juana Ambriz de Williams
Family · Valparaiso, INNPI 1083081129
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 78 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 16.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,662, more than ten times the $143 reported in 2021. Among family clinicians in IN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 78 payments — averaging $49.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$647
- Neurocrine Biosciences, Inc.$401
- Otsuka America Pharmaceutical, Inc.$376
- Idorsia Pharmaceuticals US Inc$367
- Teva Pharmaceuticals USA, Inc.$355
- Corium, LLC$277
- plus $1K from 14 others
What the payments were for
- Food & beverage$3,851100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 13 | $647 |
| Neurocrine Biosciences, Inc. | 11 | $401 |
| Otsuka America Pharmaceutical, Inc. | 5 | $376 |
| Idorsia Pharmaceuticals US Inc | 5 | $367 |
| Teva Pharmaceuticals USA, Inc. | 7 | $355 |
| Corium, LLC | 6 | $277 |
| Axsome Therapeutics, Inc. | 4 | $275 |
| Harmony Biosciences LLC | 7 | $209 |
| E.r. Squibb & Sons, L.L.C. | 4 | $153 |
| Alkermes, Inc. | 2 | $143 |
| Exact Sciences | 1 | $125 |
| AbbVie | 2 | $120 |
| Johnson & Johnson | 1 | $110 |
| Lilly USA, LLC | 1 | $104 |
| Vanda Pharmaceuticals Inc. | 3 | $63 |
| Almatica Pharma LLC | 2 | $47 |
| Saluda Medical Americas, Inc. | 1 | $27 |
| Novartis | 1 | $19 |
| Gilead | 1 | $17 |
| Lundbeck LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CAPLYTA$510
- REXULTI$327
- QUVIVIQ$326
- UZEDY$239
- Azstarys$132
- The Cologuard Plus Collection Kit$125
- Auvelity$117
- INVEGA SUSTENNA$110
- INVEGA TRINZA$110
- MOUNJARO$104
How this compares
$3,851 in reported general payments places this provider in the 90th percentile of 4,392 family providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 12 | $251 |
| Tramadol Hcl | 18 | $103 |
| Lisinopril | 13 | $25 |
Paid to pharmacies, not to this prescriber.
Other family in Valparaiso
- Tina SizemoreIndianapolis$888K
- Kathalene Keller RineyEvansville$383K
- Robin AndersonPortage$333K
- Marla MosesIndianapolis$142K
- Justin BrownFort Wayne$142K
- Lacey MatheisEvansville$139K
- Myra SikwataHobart$131K
- Elizabeth JohnsonEvansville$108K
- Beverly MaugerFt Wayne$94K
- Nancy ArndtPortage$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.